Clinical and histologic evaluation of an enamel matrix derivative combined with a biphasic calcium phosphate for the treatment of human intrabony periodontal defects.
暂无分享,去创建一个
F. Schwarz | J. Becker | A. Sculean | P. Windisch | A. Horváth | I. Gera | Dóra Szendröi-Kiss | P. Rosta
[1] A. Sculean,et al. Effect of an enamel matrix protein derivative (Emdogain) on ex vivo dental plaque vitality. , 2008, Journal of clinical periodontology.
[2] F. Schwarz,et al. Guided bone regeneration at dehiscence-type defects using biphasic hydroxyapatite + beta tricalcium phosphate (Bone Ceramic) or a collagen-coated natural bone mineral (BioOss Collagen): an immunohistochemical study in dogs. , 2007, International journal of oral and maxillofacial surgery.
[3] M. Dard,et al. Evaluation of a novel biphasic calcium phosphate in standardized bone defects: a histologic and histomorphometric study in the mandibles of minipigs. , 2007, Clinical oral implants research.
[4] B. Willershausen,et al. Treatment of Intrabony Defects Using Guided Tissue Regeneration and Autogenous Spongiosa Alone or Combined With Hydroxyapatite/β-Tricalcium Phosphate Bone Substitute or Bovine-Derived Xenograft. , 2007, Journal of periodontology.
[5] L. Trombelli,et al. Effect of autogenous cortical bone particulate in conjunction with enamel matrix derivative in the treatment of periodontal intraosseous defects. , 2007, Journal of periodontology.
[6] U. Schlagenhauf,et al. Primary flap closure combined with Emdogain alone or Emdogain and Cerasorb in the treatment of intra-bony defects. , 2006, Journal of clinical periodontology.
[7] N. Lang,et al. Pattern of mineralization after regenerative periodontal therapy with enamel matrix proteins. , 2006, European journal of oral sciences.
[8] A. Sculean,et al. Clinical evaluation of an enamel matrix protein derivative combined with either a natural bone mineral or beta-tricalcium phosphate. , 2005, Journal of periodontology.
[9] Z. Majzoub,et al. Two patterns of histologic healing in an intrabony defect following treatment with enamel matrix derivative: a human case report. , 2005, The International journal of periodontics & restorative dentistry.
[10] B. Pjetursson,et al. Effects of enamel matrix proteins on tissue formation along the roots of human teeth. , 2005, Journal of periodontal research.
[11] A. Sculean,et al. Clinical and histologic evaluation of an enamel matrix protein derivative combined with a bioactive glass for the treatment of intrabony periodontal defects in humans. , 2005, The International journal of periodontics & restorative dentistry.
[12] T. Karring,et al. Formation of human cementum following different modalities of regenerative therapy , 2005, Clinical Oral Investigations.
[13] M. Mills,et al. Clinical evaluation of demineralized freeze-dried bone allograft and enamel matrix derivative versus enamel matrix derivative alone for the treatment of periodontal osseous defects in humans. , 2004, Journal of periodontology.
[14] J. C. Joly,et al. The influence of enamel matrix derivative associated with insulin-like growth factor-I on periodontal ligament fibroblasts. , 2004, Journal of periodontology.
[15] A. Forlino,et al. Effect of enamel matrix derivative on human periodontal fibroblasts: proliferation, morphology and root surface colonization. An in vitro study. , 2003, Journal of periodontal research.
[16] G. Zucchelli,et al. Enamel matrix proteins and bovine porous bone mineral in the treatment of intrabony defects: a comparative controlled clinical trial. , 2003, Journal of periodontology.
[17] Markus B Hürzeler,et al. Microsurgical access flap and enamel matrix derivative for the treatment of periodontal intrabony defects: a controlled clinical study. , 2003, Journal of clinical periodontology.
[18] A. Sculean,et al. Clinical and histologic evaluation of human intrabony defects treated with an enamel matrix protein derivative combined with a bovine-derived xenograft. , 2003, The International journal of periodontics & restorative dentistry.
[19] A. Ohazama,et al. Participation of endogenous IGF-I and TGF-beta 1 with enamel matrix derivative-stimulated cell growth in human periodontal ligament cells. , 2003, Journal of periodontal research.
[20] A. Sculean,et al. Antibacterial effect of an enamel matrix protein derivative on in vivo dental biofilm vitality , 2002, Clinical Oral Investigations.
[21] J. Mellonig,et al. Clinical comparison of an enamel matrix derivative used alone or in combination with a bovine-derived xenograft for the treatment of periodontal osseous defects in humans. , 2002, Journal of periodontology.
[22] N. Lang,et al. Enamel matrix proteins in the regenerative therapy of deep intrabony defects. , 2002, Journal of clinical periodontology.
[23] E. Reich,et al. Treatment of intrabony defects with enamel matrix proteins and guided tissue regeneration. A prospective controlled clinical study. , 2001, Journal of clinical periodontology.
[24] P. Bartold,et al. Enamel matrix derivative induces matrix synthesis by cultured human periodontal fibroblast cells. , 2001, Journal of periodontology.
[25] S. Lyngstadaas,et al. Autocrine growth factors in human periodontal ligament cells cultured on enamel matrix derivative. , 2001, Journal of clinical periodontology.
[26] L. Wolff,et al. Enamel matrix derivative in the treatment of human intrabony osseous defects. , 2000, Journal of periodontology.
[27] T. Karring. Regenerative periodontal therapy. , 2000, Journal of the International Academy of Periodontology.
[28] D. Carnes,et al. Porcine fetal enamel matrix derivative stimulates proliferation but not differentiation of pre-osteoblastic 2T9 cells, inhibits proliferation and stimulates differentiation of osteoblast-like MG63 cells, and increases proliferation and differentiation of normal human osteoblast NHOst cells. , 2000, Journal of periodontology.
[29] G. Rasperini,et al. Comparison of treatments of infrabony defects with enamel matrix derivative, guided tissue regeneration with a nonresorbable membrane and Widman modified flap. A pilot study. , 2000, Journal of clinical periodontology.
[30] A. Sculean,et al. Clinical and histologic evaluation of human intrabony defects treated with an enamel matrix protein derivative (Emdogain). , 2000, The International journal of periodontics & restorative dentistry.
[31] D. M. Burns,et al. Cytostatic action of enamel matrix derivative (EMDOGAIN) on human oral squamous cell carcinoma-derived SCC25 epithelial cells. , 2000, Journal of periodontal research.
[32] Z. Aleksic,et al. A comparison between enamel matrix proteins used alone or in combination with bovine porous bone mineral in the treatment of intrabony periodontal defects in humans. , 2000, Journal of periodontology.
[33] J. Mellonig,et al. Histologic evaluation of periodontal healing in humans following regenerative therapy with enamel matrix derivative. A 10-case series. , 2000, Journal of periodontology.
[34] J. Wennström,et al. The use of barrier membranes and enamel matrix proteins in the treatment of angular bone defects. A prospective controlled clinical study. , 1999, Journal of clinical periodontology.
[35] G. Armitage,et al. Development of a classification system for periodontal diseases and conditions. , 1999, Annals of periodontology.
[36] T. Karring,et al. Healing of human intrabony defects following treatment with enamel matrix proteins or guided tissue regeneration. , 1999, Journal of periodontal research.
[37] K. Selvig,et al. Periodontal wound healing and regeneration. , 1999, Periodontology 2000.
[38] J. Mellonig. Enamel matrix derivative for periodontal reconstructive surgery: technique and clinical and histologic case report. , 1999, The International journal of periodontics & restorative dentistry.
[39] L. Heijl. Periodontal regeneration with enamel matrix derivative in one human experimental defect. A case report. , 1997, Journal of clinical periodontology.
[40] G. Heden,et al. Enamel matrix derivative (EMDOGAIN) in the treatment of intrabony periodontal defects. , 1997, Journal of clinical periodontology.
[41] C. Mangano,et al. Clinical and histologic aspects of biphasic calcium phosphate ceramic (BCP) used in connection with implant placement. , 1996, Biomaterials.
[42] S. Lindskog,et al. Smear removal and collagen exposure after non-surgical root planing followed by etching with an EDTA gel preparation. , 1996, Journal of periodontology.
[43] K. Lynch,et al. Tissue response to biphasic calcium phosphate ceramic with different ratios of HA/beta TCP in periodontal osseous defects. , 1992, Journal of periodontology.
[44] H Löe,et al. The Gingival Index, the Plaque Index and the Retention Index Systems. , 1967, Journal of periodontology.
[45] S. Froum,et al. A comparative study utilizing open flap debridement with and without enamel matrix derivative in the treatment of periodontal intrabony defects: a 12-month re-entry study. , 2001, Journal of periodontology.
[46] V. Everts,et al. Enamel matrix-derived protein stimulates attachment of periodontal ligament fibroblasts and enhances alkaline phosphatase activity and transforming growth factor beta1 release of periodontal ligament and gingival fibroblasts. , 2000, Journal of periodontology.